Industry News

Join WhatsApp Channel

28 April 2015

Launch Avycaz by Actavis in US markets to treat cIAI and complicated urinary tract infections

In the United States, Actavis plc, global pharmaceutical company, has launched Avycaz (ceftazidime-avibactam) to treat adult patients with complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible bacteria, including certain Enterobacteriaceae and Pseudomonas aeruginosa. Avycaz should be reserved for use in patients who have limited or no alternative treatment options.
- Read more about Mylan launches in India generic sofosbuvir 400 mg tablets to treat chronic hepatitis C
Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V., has launched generic sofosbuvir 400 mg tablets under the brand name MyHep in India. The product is used for the treatment of chronic hepatitis C,which is a long-lasting infection with the hepatitis C virus. Chronic hepatitis C is a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.
- Read more about B Jain Pharma introduces guateria guameri, homoeopathic drug for cholesterol
B Jain Pharmaceuticals, the leading manufacturer and distributor of homoeopathic medicines, introduced its latest product - guateria guameri, for bringing down cholesterol. The medicine is effective in treating hyperlipilidemia, which is a risk factor for cardiovascular disease.
- Read more about Mauna Kea Technologies inventor of Cellvizio receives Mexican approval
Mauna Kea Technologies, inventor of Cellvizio, the multidisciplinary confocal laser endomicroscopy platform, has received regulatory approval from COFEPRIS (Comisión Federal Para la Protección contra Riesgos Sanitarios), the Mexican health authority, for the commercialization of Cellvizio.. Mauna Kea Technologies is now able to implement its marketing strategy with its partner, Endomédica, a company specialized in the fields of interventional endoscopy, gastroenterology, urology and surgery since 1986.
- Read more about Syneron Medical's PicoWay picosecond laser approved by USFDA to treat pigmented lesions
Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that the PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for the treatment of pigmented lesions.
- Read more about Merck Collaborates with Maharashtra University to Build Diabetes and Hypertension Healthcare Capacity India
Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, in collaboration with Maharashtra University of Health Sciences and Directorate of Medical Education & Research is introducing European Accredited Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.
23 April 2015

Lupin introduce Zaxine in Canada for liver disease treatment

Pharma Major Lupin’s Canadian subsidiary, Lupin Pharma Canada has launched its first Brand product Zaxine under a strategic licensing agreement with the North Carolina based GI specialty company Salix Pharmaceuticals Inc. The agreement grants Lupin exclusive rights to promote, distribute and market Zaxine in the Canada.
- Read more about AstraZeneca's selumetinib get US FDA orphan drug status for uveal melanoma treatment
AstraZeneca, a global, innovation-driven biopharmaceutical business, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for the MEK inhibitor selumetinib, for the treatment of uveal melanoma.
- Read more about Comfortably Numb Device arrest Pain of Drug Injections
A team of three engineering students from Rice University, Houston, United States, created the device to ease the pain of an injection. A new drug injector called "Comfortably Numb" is a cooling device. It numbs the skin prior to getting a shot. It works like an ice pack, which produces a rapid chemical reaction that cools and numbs patients' skin in seconds. The device consists of a small 3D-printed cylinder with a metal plate at one end. It contain ammonium nitrate and water in separate compartments.
- Read more about Aeterna Zentaris plans to conduct phase 3 study of Macrilen in AGHD
Aeterna Zentaris Inc., a specialty biopharmaceutical company, is planning to conduct a new, confirmatory phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency (AGHD), as well as a dedicated thorough QT study to evaluate the effect of Macrilen on myocardial repolarisation.